22 May 2013
Keywords: reneuron, gets, nod, stem, cell, stroke, trial
Article | 26 January 2009
ReNeuron has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence a first-in-man trial of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 January 2009
© 2013 thepharmaletter.com